COMPANY
SurgiVance
Funding and NIH signals
- NIH award NIH awarded $1.27M (SBIR Phase II 5R44CA302122-02, continuation, notice Jun 3, 2026). NIH RePORTER 5R44CA302122-02 (Jun 3, 2026)
Evidence (1 event)
- Jun 3, 2026 · NIH RePORTER 5R44CA302122-02
Organization: SURGIVANCE, INC.; City/State: Portland, OR; Project number: 5R44CA302122-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-06-03; FY total cost (award amount): 1271776; Administering IC: National Cancer Institute; Project title: Rapid 3D POC digital cancer pathology by unique confocal microscopy instrumentation and downstream AI: a simple, efficient, robust direct-to-digital approach to meet market demand; Organization type: Domestic For-Profits
- Jun 3, 2026 · NIH RePORTER 5R44CA302122-02
Timeline
- Grant Government grant — SBIR: $1.27M (annual award, as published), announced Jun 3, 2026. Agency: NIH/NCI. Source: government award database. source ↗
- Grant Government grant — SBIR: $978,154 (annual award, as published), announced Jun 18, 2025. Agency: NIH/NCI. Source: government award database. source ↗
Funding
NIH awards 4
- NIH award 5R44CA235915-03 FY2024: $1,007,907 awarded for that fiscal year; activity R44 (SBIR); PI GAREAU, DANIEL SUMMER; recipient as written: SURGIVANCE, INC., Portland, OR. Advanced Surgical Pathology Device source ↗
- NIH award 2R44CA235915-02 FY2023: $1,020,044 awarded for that fiscal year; activity R44 (SBIR); PI HAWKES, JASON EZRA; recipient as written: SURGIVANCE, INC., Portland, OR. Advanced Surgical Pathology Device source ↗
- NIH award 3R43CA235915-01A1S1 FY2021: $192,500 awarded for that fiscal year; activity R43 (SBIR); PI GAREAU, DANIEL SUMMER; recipient as written: SURGIVANCE, INC., Portland, OR. Advanced Surgical Pathology Device source ↗
- NIH award 1R43CA235915-01A1 FY2019: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI GAREAU, DANIEL SUMMER; recipient as written: SURGIVANCE, INC., Portland, OR. Advanced Surgical Pathology Device source ↗